Goodwin Procter LLP advised Tessera Therapeutics on the deal. Tessera Therapeutics, an early-stage life sciences company founded by Flagship Pioneering, announced today that it has raised...
Tessera Therapeutics’ $230 million Series B Financing Round
Valo Health’s $300 Million Million Series B Funding Round
Goodwin Procter LLP advised Valo Health on the deal. Valo Health announced the final closing of its Series B at $300 million, including a $110 million...